BCL2 and neoplasm: Conversely, targeting BCL-XL, a mitochondrial antiapoptotic Bcl2 family member, with the specific BCL-XL inhibitor BXI-72, achieved a significant inhibition of tumor growth in the conditional SyS mouse model, indicating this molecule as a possible target in SyS [41].